Mental healthcare company developing and delivering evidence-based psychedelics therapies Numinus Wellness Inc. (TSXV: NUMI) announced having received a conditional approval from the Toronto Stock Exchange (TSX) to graduate its listing from the TSX Venture Exchange (TSXV) to Toronto Stock Exchange.
The final approval of the listing is subject to various regulatory standard and customary conditions which the company must first fulfill. The company’s founder and chief executive officer, Payton Nyquvest, says the company’s management is working diligently to meet these conditions.
“This is an important milestone for Numinus, as we take key steps to heighten our corporate profile and reach a broader range of investors. Today’s announcement is reflective of many exciting developments occurring at Numinus. We’re actively growing our clinic network across North America, expanding our lab capabilities, and strategically investing in clinical research to drive long-term value creation for our investors,” said the CEO.
Following listing on the Toronto Stock Exchange, the company’s shares will continue trading using the under the ticker symbol ‘NUMI’.
The CEO further affirmed that they will be announcing a timeline for graduation once they receive the final approval.
